RNA Homepage / Briefings

Sessions

Building a Common Digital Approach to Unleash the Sector: An Industry Consensus

Development of a Robust Scalable Suspension Platform for AAV Manufacturing up to 2000L

How to Deliver a Fully Funded, 3rd Party Biotech Facility 3 Years Faster Than Traditional Build Construction Method

Cell Sorter for Next CT Products : Sangamo & Sony Biotechnology Journey

Ancillary Material Considerations for a Seamless Transition into GMP Manufacturing

Overcoming the Challenges of Outsourcing Cell & Gene Therapy Trials

Leveraging Partnerships to Achieve Clinical & Commercial Success

De-Risk. Deploy. Deliver. Key Considerations to Pick the Right CDMO During your Cell Therapy Development Process

Back

Building a Common Digital Approach to Unleash the Sector: An Industry Consensus

19 Jan 2023

17:00

Briefing 2

SPONSORED BY

Critical to the advancement of cell and gene therapies is the digital and data infrastructure underpinning development, manufacturing and commercialization. But few organizations have been able to address these challenges, with solutions fragmented and not addressing all the stakeholders’ needs. Join this executive briefing to understand the collective barriers to seamless digital, data and systems infrastructure integration and to be part of shaping a consensus as to the way forward. The discussion will focus on challenges related (but not limited) to data quality, data flow, connection and especially challenges at the interfaces.

Points for discussion

This is a unique opportunity to be integral in defining solutions to digital infrastructure, data and systems challenges, through a pre-competitive and collaborative environment with guided activities and discussions in order to:

• Drive consensus, alignment and collaboration in the CGT community around critical needs – and provide you with a landscape of the challenges and how they can be addressed

• Understand the diverse needs and opportunities, from across the CGT value chain, with leaders participating from academia, industry, regulatory agencies, facility developers, equipment manufacturers, providers in the automation, healthcare and digital industries

Agenda

5:00pm Panel

5:40pm Q&A

Speakers:

Paolo Siciliano, Cell & Gene Expert, PA Consulting

Stephen Ward, Chief Manufacturing Officer, Cell & Gene Therapy Catapult

Andrew Earnshaw, Digital Health Expert, PA Consulting

Phil Vanek, Chief Technology Officer, Gamma Biosciences

Fabio Fachin, Head of Cell Therapy Process Development, Takeda

Speakers